Cancer immunotherapy: Nanodelivery approaches for immune cell targeting and tracking

Frontiers in Chemistry

Volumn 2, Issue NOV, 2014, Pages

  Conniot, João ^a   Silva, Joana M ^a   Fernandes, Joana G ^a   Silva, Liana C ^a   Gaspar, Rogério ^a   Brocchini, Steve ^b   Florindo, Helena F ^a   Barata, Teresa S ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; Cell tracking; Immunotherapy; Nanosystems; Targeted delivery

Indexed keywords

EID: 84987618944     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00105     Document Type: Review

References (329)

1. Abraham, S. A., Waterhouse, D. N., Mayer, L. D., Cullis, P. R., Madden, T. D., and Bally, M. B. (2005). The liposomal formulation of doxorubicin. Meth. Enzymol. 391, 71-97. doi: 10.1016/S0076-6879(05)91004-5
2. Agemy, L., Sugahara, K. N., Kotamraju, V. R., Gujraty, K., Girard, O. M., Kono, Y., et al. (2010). Nanoparticle-induced vascular blockade in human prostate cancer. Blood 116, 2847-2856. doi: 10.1182/blood-2010-03-274258
3. Ahlers, J. D., and Belyakov, I. M. (2010). Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 115, 1678-1689. doi: 10.1182/blood-2009-06-227546
4. Ahmad, M., Rees, R. C., and Ali, S. A. (2004). Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol. Immunother. 53, 844-854. doi: 10.1007/s00262-004-0540-x
5. Ahrens, E. T., and Bulte, J. W. (2013). Tracking immune cells in vivo using magnetic resonance imaging. Nat. Rev. Immunol. 13, 755-763. doi: 10.1038/nri3531
6. Ahrens, E. T., Feili-Hariri, M., Xu, H., Genove, G., and Morel, P. A. (2003). Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn. Reson. Med. 49, 1006-1013. doi: 10.1002/mrm.10465
7. Ahrens, E. T., Flores, R., Xu, H., and Morel, P. A. (2005). In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23, 983-987. doi: 10.1038/nbt1121
8. Al-Hanbali, O., Rutt, K. J., Sarker, D. K., Hunter, A. C., and Moghimi, S. M. (2006). Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J. Nanosci. Nanotechnol. 6, 3126-3133. doi: 10.1166/jnn.2006.406
9. Albertsson, A.-C. (2002). Degradable Aliphatic Polyesters. Berlin; London: Springer.
10. Alexis, F., Pridgen, E., Molnar, L. K., and Farokhzad, O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515. doi: 10.1021/mp800051m
11. Arbab, A. S., Pandit, S. D., Anderson, S. A., Yocum, G. T., Bur, M., Frenkel, V., et al. (2006). Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24, 671-678. doi: 10.1634/stemcells.2005-0017
12. Arbab, A. S., Yocum, G. T., Kalish, H., Jordan, E. K., Anderson, S. A., Khakoo, A. Y., et al. (2004). Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104, 1217-1223. doi: 10.1182/blood-2004-02-0655
13. Arbab, A. S., Yocum, G. T., Rad, A. M., Khakoo, A. Y., Fellowes, V., Read, E. J., et al. (2005). Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18, 553-559. doi: 10.1002/nbm.991
14. Aslan, B., Ozpolat, B., Sood, A. K., and Lopez-Berestein, G. (2013). Nanotechnology in cancer therapy. J. Drug Target. 21, 904-913. doi: 10.3109/1061186X.2013.837469
15. Bachmann, M. F., and Jennings, G. T. (2010). Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787-796. doi: 10.1038/nri2868
16. Ballou, B., Ernst, L. A., Andreko, S., Harper, T., Fitzpatrick, J. A., Waggoner, A. S., et al. (2007). Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug. Chem. 18, 389-396. doi: 10.1021/bc060261j
17. Ballou, B., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., and Waggoner, A. S. (2004). Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15, 79-86. doi: 10.1021/bc034153y
18. Banchereau, J., Paczesny, S., Blanco, P., Bennett, L., Pascual, V., Fay, J., et al. (2003). Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann. N.Y. Acad. Sci. 987, 180-187. doi: 10.1111/j.1749-6632.2003.tb06047.x
19. Banchereau, J., Schuler-Thurner, B., Palucka, A. K., and Schuler, G. (2001). Dendritic cells as vectors for therapy. Cell 106, 271-274. doi: 10.1016/S0092-8674(01)00448-2
20. Benoit, M. A., Baras, B., and Gillard, J. (1999). Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm. 184, 73-84.
21. Berinstein, N. L., Karkada, M., Morse, M. A., Nemunaitis, J. J., Chatta, G., Kaufman, H., et al. (2012). First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J. Transl. Med. 10, 156. doi: 10.1186/1479-5876-10-156
22. Bernsen, M. R., Vaissier, P. E., Van Holen, R., Booij, J., Beekman, F. J., and De Jong, M. (2014). The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI. Eur. J. Nucl. Med. Mol. Imaging 41(Suppl. 1), S36-S49. doi: 10.1007/s00259-013-2685-3
23. Betancourt, T., Byrne, J. D., Sunaryo, N., Crowder, S. W., Kadapakkam, M., Patel, S., et al. (2009). PEGylation strategies for active targeting of PLA/PLGA nanoparticles. J. Biomed. Mater. Res. A 91, 263-276. doi: 10.1002/jbm.a.32247
24. Biswas, S. K., and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896. doi: 10.1038/ni.1937
25. Blanco, E., Kessinger, C. W., Sumer, B. D., and Gao, J. (2009). Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. (Maywood). 234, 123-131. doi: 10.3181/0808-MR-250
26. Bodey, B., Siegel, S. E., and Kaiser, H. E. (2004). Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy. In Vivo 18, 81-100.
27. Bos, R., Marquardt, K. L., Cheung, J., and Sherman, L. A. (2012). Functional differences between low-and high-affinity CD8(+) T cells in the tumor environment. Oncoimmunology 1, 1239-1247. doi: 10.4161/onci.21285
28. Brocchini, S., Godwin, A., Balan, S., Choi, J. W., Zloh, M., and Shaunak, S. (2008). Disulfide bridge based PEGylation of proteins. Adv. Drug Deliv. Rev. 60, 3-12. doi: 10.1016/j.addr.2007.06.014
29. Budhu, S., Wolchok, J., and Merghoub, T. (2014). The importance of animal models in tumor immunity and immunotherapy. Curr. Opin. Genet. Dev. 24, 46-51. doi: 10.1016/j.gde.2013.11.008
30. Bulte, J. W., Douglas, T., Witwer, B., Zhang, S. C., Strable, E., Lewis, B. K., et al. (2001). Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141-1147. doi: 10.1038/nbt1201-1141
31. Bulte, J. W., and Kraitchman, D. L. (2004). Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484-499. doi: 10.1002/nbm.924
32. Burnet, M. (1957). Cancer; a biological approach. I. The processes of control. Br. Med. J. 1, 779-786.
33. Bussolati, B., Grange, C., and Camussi, G. (2011). Tumor exploits alternative strategies to achieve vascularization. FASEB J. 25, 2874-2882. doi: 10.1096/fj.10-180323
34. Cai, W., Chen, K., Li, Z. B., Gambhir, S. S., and Chen, X. (2007). Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48, 1862-1870. doi: 10.2967/jnumed.107.043216
35. Cai, W., and Chen, X. (2007). Nanoplatforms for targeted molecular imaging in living subjects. Small 3, 1840-1854. doi: 10.1002/smll.200700351
36. Cai, W., Shin, D. W., Chen, K., Gheysens, O., Cao, Q., Wang, S. X., et al. (2006). Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 6, 669-676. doi: 10.1021/nl052405t
37. Cai, X., Yin, Y., Li, N., Zhu, D., Zhang, J., Zhang, C. Y., et al. (2012). Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J. Mol. Cell Biol. 4, 341-343. doi: 10.1093/jmcb/mjs044
38. Carrillo-Conde, B., Song, E. H., Chavez-Santoscoy, A., Phanse, Y., Ramer-Tait, A. E., Pohl, N. L., et al. (2011). Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. Mol. Pharm. 8, 1877-1886. doi: 10.1021/mp200213r
39. Carpenito, C., Milone, M. C., Hassan, R., Simonet, J. C., Lakhal, M., Suhoski, M. M., et al. (2009). Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc. Natl. Acad. Sci. U.S.A. 106, 3360-3365. doi: 10.1073/pnas.0813101106
40. Chan, K. W., Bulte, J. W., and McMahon, M. T. (2014). Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 6, 111-124. doi: 10.1002/wnan.1246
41. Chapuis, F., Rosenzwajg, M., Yagello, M., Ekman, M., Biberfeld, P., and Gluckman, J. C. (1997). Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27, 431-441. doi: 10.1002/eji.1830270213
42. Chen, M., Ouyang, H., Zhou, S., Li, J., and Ye, Y. (2014a). PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses. Cell. Immunol. 287, 91-99. doi: 10.1016/j.cellimm.2014.01.003
43. Chen, Y., Gu, H., Zhang, D. S., Li, F., Liu, T., and Xia, W. (2014b). Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier. Biomaterials 35, 10058-10069. doi: 10.1016/j.biomaterials.2014.09.003
44. Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., et al. (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28, 869-876. doi: 10.1016/j.biomaterials.2006.09.047
45. Cheong, C., Matos, I., Choi, J. H., Dandamudi, D. B., Shrestha, E., Longhi, M. P., et al. (2010). Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143, 416-429. doi: 10.1016/j.cell.2010.09.039
46. Chipman, S. D., Oldham, F. B., Pezzoni, G., and Singer, J. W. (2006). Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate. Int. J. Nanomedicine 1, 375-383.
47. Cho, N. H., Cheong, T. C., Min, J. H., Wu, J. H., Lee, S. J., Kim, D., et al. (2011). A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6, 675-682. doi: 10.1038/nnano.2011.149
48. Chow, E. K., and Ho, D. (2013). Cancer nanomedicine: from drug delivery to imaging. Sci. Transl. Med. 5, 216rv214. doi: 10.1126/scitranslmed.3005872
49. Christian, D. A., Cai, S., Bowen, D. M., Kim, Y., Pajerowski, J. D., and Discher, D. E. (2009). Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur. J. Pharm. Biopharm. 71, 463-474. doi: 10.1016/j.ejpb.2008.09.025
50. Colvin, E. K. (2014). Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front. Oncol. 4:137. doi: 10.3389/fonc.2014.00137
51. Conde, J., Bao, C., Cui, D., Baptista, P. V., and Tian, F. (2014). Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics. J. Control. Release 183, 87-93. doi: 10.1016/j.jconrel.2014.03.045
52. Condeelis, J., and Pollard, J. W. (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266. doi: 10.1016/j.cell.2006.01.007
53. Cornelissen, R., Lievense, L. A., Maat, A. P., Hendriks, R. W., Hoogsteden, H. C., Bogers, A. J., et al. (2014). Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. PLoS ONE 9:e106742. doi: 10.1371/journal.pone.0106742
54. Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., et al. (2012). Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U.S.A. 109, 2491-2496. doi: 10.1073/pnas.1113744109
55. Couvreur, P., Stella, B., Reddy, L. H., Hillaireau, H., Dubernet, C., Desmaele, D., et al. (2006). Squalenoyl nanomedicines as potential therapeutics. Nano Lett. 6, 2544-2548. doi: 10.1021/nl061942q
56. Cruz, L. J., Tacken, P. J., Bonetto, F., Buschow, S. I., Croes, H. J., Wijers, M., et al. (2011). Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. Mol. Pharm. 8, 520-531. doi: 10.1021/mp100356k
57. Daldrup-Link, H. E., Meier, R., Rudelius, M., Piontek, G., Piert, M., Metz, S., et al. (2005). In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur. Radiol. 15, 4-13. doi: 10.1007/s00330-004-2526-7
58. Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., and Preat, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161, 505-522. doi: 10.1016/j.jconrel.2012.01.043
59. Danhier, F., Feron, O., and Preat, V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148, 135-146. doi: 10.1016/j.jconrel.2010.08.027
60. Davidson, W. F., Giese, T., and Fredrickson, T. N. (1998). Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J. Exp. Med. 187, 1825-1838.
61. De Vries, I. J., Krooshoop, D. J., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J. H., Van Muijen, G. N., et al. (2003). Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63, 12-17.
62. De Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., Van Krieken, J. H., Boerman, O. C., et al. (2005). Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413. doi: 10.1038/nbt1154
63. Denardo, S. J., Denardo, G. L., Natarajan, A., Miers, L. A., Foreman, A. R., Gruettner, C., et al. (2007). Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. J. Nucl. Med. 48, 437-444.
64. Desmaele, D., Gref, R., and Couvreur, P. (2012). Squalenoylation: a generic platform for nanoparticular drug delivery. J. Control. Release 161, 609-618. doi: 10.1016/j.jconrel.2011.07.038
65. Devaraj, N. K., Keliher, E. J., Thurber, G. M., Nahrendorf, M., and Weissleder, R. (2009). 18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug. Chem. 20, 397-401. doi: 10.1021/bc8004649
66. Dhodapkar, M. V., Dhodapkar, K. M., and Palucka, A. K. (2008). Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ. 15, 39-50. doi: 10.1038/sj.cdd.4402247
67. Dilnawaz, F., Singh, A., Mohanty, C., and Sahoo, S. K. (2010). Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31, 3694-3706. doi: 10.1016/j.biomaterials.2010.01.057
68. Diwan, M., Tafaghodi, M., and Samuel, J. (2002). Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J. Control. Release 85, 247-262. doi: 10.1016/S0168-3659(02)00275-4
69. Dougan, M., Li, D., Neuberg, D., Mihm, M., Googe, P., Wong, K. K., et al. (2011). A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J. Clin. Invest. 121, 2436-2446. doi: 10.1172/JCI44796
70. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., and Schreiber, R. D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998. doi: 10.1038/ni1102-991
71. Dzhagalov, I. L., Melichar, H. J., Ross, J. O., Herzmark, P., and Robey, E. A. (2012). Two-photon imaging of the immune system. Curr. Protoc. Cytom. Chapter 12, Unit12 26. doi: 10.1002/0471142956.cy1226s60
72. Eerola, A. K., Soini, Y., and Paakko, P. (2000). A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin. Cancer Res. 6, 1875-1881.
73. Ehmann, F., Sakai-Kato, K., Duncan, R., Hernan Perez De La Ossa, D., Pita, R., Vidal, J. M., et al. (2013). Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines. Nanomedicine (Lond). 8, 849-856. doi: 10.2217/nnm.13.68
74. Ehrlich, P. (1909). Beiträge zur Experimentellen Pathologie und Chemotherapie. Leipzig: Akademische Verlagsgesellschaft.
75. Engels, B., Engelhard, V. H., Sidney, J., Sette, A., Binder, D. C., Liu, R. B., et al. (2013). Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell 23, 516-526. doi: 10.1016/j.ccr.2013.03.018
76. Ercolini, A. M., Ladle, B. H., Manning, E. A., Pfannenstiel, L. W., Armstrong, T. D., Machiels, J. P., et al. (2005). Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J. Exp. Med. 201, 1591-1602. doi: 10.1084/jem.20042167
77. Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., et al. (2012). Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 72, 1070-1080. doi: 10.1158/0008-5472.CAN-11-3218
78. Escribese, M. M., Casas, M., and Corbi, A. L. (2012). Influence of low oxygen tensions on macrophage polarization. Immunobiology 217, 1233-1240. doi: 10.1016/j.imbio.2012.07.002
79. Ewert, K., Evans, H. M., Ahmad, A., Slack, N. L., Lin, A. J., Martin-Herranz, A., et al. (2005). Lipoplex structures and their distinct cellular pathways. Adv. Genet. 53, 119-155. doi: 10.1016/S0065-2660(05)53005-0
80. Fang, J., Nakamura, H., and Maeda, H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63, 136-151. doi: 10.1016/j.addr.2010.04.009
81. Fernald, K., and Kurokawa, M. (2013). Evading apoptosis in cancer. Trends Cell Biol. 23, 620-633. doi: 10.1016/j.tcb.2013.07.006
82. Florindo, H. F., Pandit, S., Goncalves, L. M., Alpar, H. O., and Almeida, A. J. (2008). Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine 26, 4168-4177. doi: 10.1016/j.vaccine.2008.05.074
83. Florindo, H. F., Pandit, S., Goncalves, L. M., Videira, M., Alpar, O., and Almeida, A. J. (2009a). Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres. Biomaterials 30, 5161-5169. doi: 10.1016/j.biomaterials.2009.05.045
84. Florindo, H. F., Pandit, S., Lacerda, L., Goncalves, L. M., Alpar, H. O., and Almeida, A. J. (2009b). The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles. Biomaterials 30, 879-891. doi: 10.1016/j.biomaterials.2008.10.035
85. Foged, C., Brodin, B., Frokjaer, S., and Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 298, 315-322. doi: 10.1016/j.ijpharm.2005.03.035
86. Fong, L., and Engleman, E. G. (2000). Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18, 245-273. doi: 10.1146/annurev.immunol.18.1.245
87. Fortis, C., Foppoli, M., Gianotti, L., Galli, L., Citterio, G., Consogno, G., et al. (1996). Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett. 104, 1-5.
88. Frank, J. A., Miller, B. R., Arbab, A. S., Zywicke, H. A., Jordan, E. K., Lewis, B. K., et al. (2003). Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228, 480-487. doi: 10.1148/radiol.2281020638
89. Frank, M. M. (1993). The reticuloendothelial system and bloodstream clearance. J. Lab. Clin. Med. 122, 487-488.
90. Freichels, H., Pourcelle, V., Auzely-Velty, R., Marchand-Brynaert, J., and Jerome, C. (2012). Synthesis of poly(lactide-co-glycolide-co-epsilon-caprolactone)-graft-mannosylated poly(ethylene oxide) copolymers by combination of "clip" and "click" chemistries. Biomacromolecules 13, 760-768. doi: 10.1021/bm201690w
91. + T cell responses through CD8(alpha)+ dendritic cells. J. Exp. Med. 208, 2005-2016. doi: 10.1084/jem.20101159
92. Gajewski, T. F. (2012). Cancer immunotherapy. Mol. Oncol. 6, 242-250. doi: 10.1016/j.molonc.2012.01.002
93. Gajewski, T. F., Schreiber, H., and Fu, Y. X. (2013). Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014-1022. doi: 10.1038/ni.2703
94. Gajos-Michniewicz, A., Duechler, M., and Czyz, M. (2014). MiRNA in melanoma-derived exosomes. Cancer Lett. 347, 29-37. doi: 10.1016/j.canlet.2014.02.004
95. Ganta, S., Devalapally, H., Shahiwala, A., and Amiji, M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 126, 187-204. doi: 10.1016/j.jconrel.2007.12.017
96. Gao, H., Xiong, Y., Zhang, S., Yang, Z., Cao, S., and Jiang, X. (2014). RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol. Pharm. 11, 1042-1052. doi: 10.1021/mp400751g
97. Gao, X., Cui, Y., Levenson, R. M., Chung, L. W., and Nie, S. (2004). In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976. doi: 10.1038/nbt994
98. Garrido, F., and Algarra, I. (2001). MHC antigens and tumor escape from immune surveillance. Adv. Cancer Res. 83, 117-158. doi: 10.1016/S0065-230X(01)83005-0
99. Gelperina, S., Kisich, K., Iseman, M. D., and Heifets, L. (2005). The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med. 172, 1487-1490. doi: 10.1164/rccm.200504-613PP
100. Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., et al. (2011). Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5, 4422-4433. doi: 10.1021/nn103336a
101. Gilad, A. A., Walczak, P., McMahon, M. T., Na, H. B., Lee, J. H., An, K., et al. (2008). MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn. Reson. Med. 60, 1-7. doi: 10.1002/mrm.21622
102. Gilewski, T. A., Ragupathi, G., Dickler, M., Powell, S., Bhuta, S., Panageas, K., et al. (2007). Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clin. Cancer Res. 13, 2977-2985. doi: 10.1158/1078-0432.CCR-06-2189
103. Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., et al. (2001). Regulation of cutaneous malignancy by gammadelta T cells. Science 294, 605-609. doi: 10.1126/science.1063916
104. Gogolak, P., Rethi, B., Hajas, G., and Rajnavolgyi, E. (2003). Targeting dendritic cells for priming cellular immune responses. J. Mol. Recognit. 16, 299-317. doi: 10.1002/jmr.650
105. Gooden, M. J., De Bock, G. H., Leffers, N., Daemen, T., and Nijman, H. W. (2011). The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br. J. Cancer 105, 93-103. doi: 10.1038/bjc.2011.189
106. Gorner, T., Gref, R., Michenot, D., Sommer, F., Tran, M. N., and Dellacherie, E. (1999). Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. J. Control. Release 57, 259-268.
107. Grange, C., Geninatti-Crich, S., Esposito, G., Alberti, D., Tei, L., Bussolati, B., et al. (2010). Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. Cancer Res. 70, 2180-2190. doi: 10.1158/0008-5472.CAN-09-2821
108. Gratton, S. E., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., et al. (2008). The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U.S.A. 105, 11613-11618. doi: 10.1073/pnas.0801763105
109. Greenberg, N. M., Demayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., et al. (1995). Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 92, 3439-3443.
110. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667. doi: 10.1146/annurev.immunol.20.100301.064828
111. Hamdy, S., Haddadi, A., Hung, R. W., and Lavasanifar, A. (2011). Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv. Drug Deliv. Rev. 63, 943-955. doi: 10.1016/j.addr.2011.05.021
112. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. doi: 10.1016/S0092-8674(00)81683-9
113. Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., Van De Kaa, C. H., et al. (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491-2499. doi: 10.1056/NEJMoa022749
114. Hashim, Z., Green, M., Chung, P. H., Suhling, K., Protti, A., Phinikaridou, A., et al. (2014). Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging. Nanoscale 6, 8376-8386. doi: 10.1039/c4nr01491j
115. Hawrylak, N., Ghosh, P., Broadus, J., Schlueter, C., Greenough, W. T., and Lauterbur, P. C. (1993). Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp. Neurol. 121, 181-192. doi: 10.1006/exnr.1993.1085
116. He, X., Chen, J., Wang, K., Qin, D., and Tan, W. (2007). Preparation of luminescent Cy5 doped core-shell SFNPs and its application as a near-infrared fluorescent marker. Talanta 72, 1519-1526. doi: 10.1016/j.talanta.2007.01.069
117. He, X., Duan, J., Wang, K., Tan, W., Lin, X., and He, C. (2004). A novel fluorescent label based on organic dye-doped silica nanoparticles for HepG liver cancer cell recognition. J. Nanosci. Nanotechnol. 4, 585-589. doi: 10.1166/jnn.2004.011
118. He, X., Wang, K., Tan, W., Li, J., Yang, X., Huang, S., et al. (2002). Photostable luminescent nanoparticles as biological label for cell recognition of system lupus erythematosus patients. J. Nanosci. Nanotechnol. 2, 317-320. doi: 10.1166/jnn.2002.105
119. Helfer, B. M., Balducci, A., Nelson, A. D., Janjic, J. M., Gil, R. R., Kalinski, P., et al. (2010). Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 12, 238-250. doi: 10.3109/14653240903446902
120. Helmy, K. Y., Patel, S. A., Nahas, G. R., and Rameshwar, P. (2013). Cancer immunotherapy: accomplishments to date and future promise. Ther. Deliv. 4, 1307-1320. doi: 10.4155/tde.13.88
121. Henderson, R. A., Mossman, S., Nairn, N., and Cheever, M. A. (2005). Cancer vaccines and immunotherapies: emerging perspectives. Vaccine 23, 2359-2362. doi: 10.1016/j.vaccine.2005.01.082
122. Herwig, M. C., Bergstrom, C., Wells, J. R., Holler, T., and Grossniklaus, H. E. (2013). M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp. Eye Res. 107, 52-58. doi: 10.1016/j.exer.2012.11.012
123. Higgins, J. P., Bernstein, M. B., and Hodge, J. W. (2009). Enhancing immune responses to tumor-associated antigens. Cancer Biol. Ther. 8, 1440-1449. doi: 10.4161/cbt.8.15.9133
124. Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., et al. (2008). Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100. doi: 10.1126/science.1164206
125. Hillaireau, H., and Couvreur, P. (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873-2896. doi: 10.1007/s00018-009-0053-z
126. Hinrichs, C. S., Borman, Z. A., Gattinoni, L., Yu, Z., Burns, W. R., Huang, J., et al. (2011). Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood 117, 808-814. doi: 10.1182/blood-2010-05-286286
127. Hong, H., Yang, K., Zhang, Y., Engle, J. W., Feng, L., Yang, Y., et al. (2012). In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 6, 2361-2370. doi: 10.1021/nn204625e
128. Hughes, M. S., Marsh, J. N., Zhang, H., Woodson, A. K., Allen, J. S., Lacy, E. K., et al. (2006). Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 53, 1609-1616. doi: 10.1109/TUFFC.2006.1678189
129. Hurwitz, A. A., Foster, B. A., Kwon, E. D., Truong, T., Choi, E. M., Greenberg, N. M., et al. (2000). Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res. 60, 2444-2448.
130. Huwyler, J., Drewe, J., and Krahenbuhl, S. (2008). Tumor targeting using liposomal antineoplastic drugs. Int. J. Nanomedicine 3, 21-29. doi: 10.2147/IJN.S1253
131. Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., et al. (2013). Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br. J. Cancer 108, 914-923. doi: 10.1038/bjc.2013.32
132. Ivkov, R., Denardo, S. J., Daum, W., Foreman, A. R., Goldstein, R. C., Nemkov, V. S., et al. (2005). Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin. Cancer Res. 11, 7093s-7103s. doi: 10.1158/1078-0432.CCR-1004-0016
133. Iyer, A. K., Khaled, G., Fang, J., and Maeda, H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11, 812-818. doi: 10.1016/j.drudis.2006.07.005
134. Jain, T. K., Foy, S. P., Erokwu, B., Dimitrijevic, S., Flask, C. A., and Labhasetwar, V. (2009). Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 30, 6748-6756. doi: 10.1016/j.biomaterials.2009.08.042
135. Jang, B., Park, S., Kang, S. H., Kim, J. K., Kim, S. K., Kim, I. H., et al. (2012). Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo. Quant. Imaging Med. Surg. 2, 1-11. doi: 10.3978/.issn.2223-4292.2012.01.03
136. Janjic, J. M., and Ahrens, E. T. (2009). Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 492-501. doi: 10.1002/wnan.35
137. Jarrett, B. R., Gustafsson, B., Kukis, D. L., and Louie, A. Y. (2008). Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. Bioconjug. Chem. 19, 1496-1504. doi: 10.1021/bc800108v
138. Jhaveri, A. M., and Torchilin, V. P. (2014). Multifunctional polymeric micelles for delivery of drugs and siRNA. Front. Pharmacol. 5:77. doi: 10.3389/fphar.2014.00077
139. Johansen, P., Estevez, F., Zurbriggen, R., Merkle, H. P., Gluck, R., Corradin, G., et al. (2000). Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres. Vaccine 19, 1047-1054. doi: 10.1016/S0264-410X(00)00343-1
140. Joshi, P. P., Yoon, S. J., Chen, Y. S., Emelianov, S., and Sokolov, K. V. (2013). Development and optimization of near-IR contrast agents for immune cell tracking. Biomed. Opt. Express 4, 2609-2618. doi: 10.1364/BOE.4.002609
141. Kaida, S., Cabral, H., Kumagai, M., Kishimura, A., Terada, Y., Sekino, M., et al. (2010). Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model. Cancer Res. 70, 7031-7041. doi: 10.1158/0008-5472.CAN-10-0303
142. Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., and O'Hagan, D. T. (2006). Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency. J. Control. Release 110, 566-573. doi: 10.1016/j.jconrel.2005.10.010
143. Keller, S., Wilson, J. T., Patilea, G. I., Kern, H. B., Convertine, A. J., and Stayton, P. S. (2014). Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8 T cell responses. J. Control. Release 191, 24-33. doi: 10.1016/j.jconrel.2014.03.041
144. Kenny, G. D., Kamaly, N., Kalber, T. L., Brody, L. P., Sahuri, M., Shamsaei, E., et al. (2011). Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo. J. Control. Release 149, 111-116. doi: 10.1016/j.jconrel.2010.09.020
145. Khan, D. R., Rezler, E. M., Lauer-Fields, J., and Fields, G. B. (2008). Effects of drug hydrophobicity on liposomal stability. Chem. Biol. Drug Des. 71, 3-7. doi: 10.1111/j.1747-0285.2007.00610.x
146. Kikkeri, R., Lepenies, B., Adibekian, A., Laurino, P., and Seeberger, P. H. (2009). In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J. Am. Chem. Soc. 131, 2110-2112. doi: 10.1021/ja807711w
147. Kim, J., Kim, H. S., Lee, N., Kim, T., Kim, H., Yu, T., et al. (2008a). Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed Engl. 47, 8438-8441. doi: 10.1002/anie.200802469
148. Kim, J., Lee, J. E., Lee, S. H., Yu, J. H., Lee, J. H., Park, T. G., et al. (2008b). Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv. Mater. 20, 478. doi: 10.1002/adma.200701726
149. Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., et al. (2004). Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22, 93-97. doi: 10.1038/nbt920
150. Kim, S. W., Zimmer, J. P., Ohnishi, S., Tracy, J. B., Frangioni, J. V., and Bawendi, M. G. (2005). Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. J. Am. Chem. Soc. 127, 10526-10532. doi: 10.1021/ja0434331
151. Kim, T. H., Jin, H., Kim, H. W., Cho, M. H., and Cho, C. S. (2006). Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol. Cancer Ther. 5, 1723-1732. doi: 10.1158/1535-7163.MCT-05-0540
152. Kindt, T. J., Goldsby, R. A., Osborne, B. A., and Kuby, J. (2006). Kuby Immunology. New York, NY; Basingstoke: W.H. Freeman.
153. Kircher, M. F., Allport, J. R., Graves, E. E., Love, V., Josephson, L., Lichtman, A. H., et al. (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63, 6838-6846.
154. Kircher, M. F., Gambhir, S. S., and Grimm, J. (2011). Noninvasive cell-tracking methods. Nat. Rev. Clin. Oncol. 8, 677-688. doi: 10.1038/nrclinonc.2011.141
155. Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., and Ferrone, S. (2012). Immunotherapy of cancer in 2012. CA Cancer J. Clin. 62, 309-335. doi: 10.3322/caac.20132
156. Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., et al. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907. doi: 10.1038/nature06309
157. Kopelman, R., Koo, Y. E. L., Philbert, M., Moffat, B. A., Reddy, G. R., McConville, P., et al. (2005). Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magn. Magn. Mater. 293, 404-410. doi: 10.1016/j.jmmm.2005.02.061
158. Krishnamachari, Y., Geary, S. M., Lemke, C. D., and Salem, A. K. (2011). Nanoparticle delivery systems in cancer vaccines. Pharm. Res. 28, 215-236. doi: 10.1007/s11095-010-0241-4
159. Krug, L. M., Ragupathi, G., Hood, C., Kris, M. G., Miller, V. A., Allen, J. R., et al. (2004). Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin. Cancer Res. 10, 6094-6100. doi: 10.1158/1078-0432.CCR-04-0482
160. Kumar, H., Kawai, T., and Akira, S. (2009). Pathogen recognition in the innate immune response. Biochem. J. 420, 1-16. doi: 10.1042/BJ20090272
161. Labet, M., and Thielemans, W. (2009). Synthesis of polycaprolactone: a review. Chem. Soc. Rev. 38, 3484-3504. doi: 10.1039/b820162p
162. Lan, C., Huang, X., Lin, S., Huang, H., Cai, Q., Wan, T., et al. (2013). Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol. Cancer Res. Treat. 12, 259-267. doi: 10.7785/tcrt.2012.500312
163. Larson, D. R., Zipfel, W. R., Williams, R. M., Clark, S. W., Bruchez, M. P., Wise, F. W., et al. (2003). Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300, 1434-1436. doi: 10.1126/science.1083780
164. Laskey, W. K., Feinendegen, L. E., Neumann, R. D., and Dilsizian, V. (2010). Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc. Imaging 3, 517-524. doi: 10.1016/j.jcmg.2009.11.017
165. Lassalle, V., and Ferreira, M. L. (2007). PLA nano-and microparticles for drug delivery: an overview of the methods of preparation. Macromol. Biosci. 7, 767-783. doi: 10.1002/mabi.200700022
166. Lee, C. C., Mackay, J. A., Frechet, J. M., and Szoka, F. C. (2005). Designing dendrimers for biological applications. Nat. Biotechnol. 23, 1517-1526. doi: 10.1038/nbt1171
167. Lee, C. S., Cragg, M., Glennie, M., and Johnson, P. (2013). Novel antibodies targeting immune regulatory checkpoints for cancer therapy. Br. J. Clin. Pharmacol. 76, 233-247. doi: 10.1111/bcp.12164
168. Lee, H. J., Nguyen, Y. T., Muthiah, M., Vu-Quang, H., Namgung, R., Kim, W. J., et al. (2012). MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles. J. Biomed. Nanotechnol. 8, 361-371. doi: 10.1166/jbn.2012.1407
169. Lee, J. H., Huh, Y. M., Jun, Y. W., Seo, J. W., Jang, J. T., Song, H. T., et al. (2007). Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13, 95-99. doi: 10.1038/nm1467
170. Lee, J. H., Lee, K., Moon, S. H., Lee, Y., Park, T. G., and Cheon, J. (2009a). All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed Engl. 48, 4174-4179. doi: 10.1002/anie.200805998
171. Lee, J. H., Smith, M. A., Liu, W., Gold, E. M., Lewis, B., Song, H. T., et al. (2009b). Enhanced stem cell tracking via electrostatically assembled fluorescent SPION-peptide complexes. Nanotechnology 20, 355102. doi: 10.1088/0957-4484/20/35/355102
172. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629.
173. Legrand, N., Ploss, A., Balling, R., Becker, P. D., Borsotti, C., Brezillon, N., et al. (2009). Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6, 5-9. doi: 10.1016/j.chom.2009.06.006
174. Levine, T. P., and Chain, B. M. (1991). The cell biology of antigen processing. Crit. Rev. Biochem. Mol. Biol. 26, 439-473. doi: 10.3109/10409239109086790
175. Li, F., Zhu, A., Song, X., Ji, L., and Wang, J. (2013). The internalization of fluorescence-labeled PLA nanoparticles by macrophages. Int. J. Pharm. 453, 506-513. doi: 10.1016/j.ijpharm.2013.06.033
176. Li, J. M., Wang, Y. Y., Zhao, M. X., Tan, C. P., Li, Y. Q., Le, X. Y., et al. (2012). Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 33, 2780-2790. doi: 10.1016/j.biomaterials.2011.12.035
177. Liang, S., Wang, Y., Yu, J., Zhang, C., Xia, J., and Yin, D. (2007). Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J. Mater. Sci. Mater. Med. 18, 2297-2302. doi: 10.1007/s10856-007-3130-6
178. Liu, K., and Rosenberg, S. A. (2001). Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity. J. Immunol. 167, 6356-6365. doi: 10.4049/jimmunol.167.11.6356
179. Liu, R. B., Engels, B., Arina, A., Schreiber, K., Hyjek, E., Schietinger, A., et al. (2012). Densely granulated murine NK cells eradicate large solid tumors. Cancer Res. 72, 1964-1974. doi: 10.1158/0008-5472.CAN-11-3208
180. Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., et al. (2007). In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47-52. doi: 10.1038/nnano.2006.170
181. Liu, Z., and Li, Z. (2014). Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs). Theranostics 4, 990-1001. doi: 10.7150/thno.9268
182. Lu, J., Feng, F., and Jin, Z. (2013). Cancer diagnosis and treatment guidance: role of MRI and MRI probes in the era of molecular imaging. Curr. Pharm. Biotechnol. 14, 714-722.
183. Lu, Y., Kawakami, S., Yamashita, F., and Hashida, M. (2007). Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials 28, 3255-3262. doi: 10.1016/j.biomaterials.2007.03.028
184. Ma, W., Chen, M., Kaushal, S., McElroy, M., Zhang, Y., Ozkan, C., et al. (2012). PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int. J. Nanomedicine 7, 1475-1487. doi: 10.2147/IJN.S29506
185. Ma, Y., Shurin, G. V., Peiyuan, Z., and Shurin, M. R. (2013). Dendritic cells in the cancer microenvironment. J. Cancer 4, 36-44. doi: 10.7150/jca.5046
186. Madru, R., Kjellman, P., Olsson, F., Wingardh, K., Ingvar, C., Stahlberg, F., et al. (2012). 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. J. Nucl. Med. 53, 459-463. doi: 10.2967/jnumed.111.092437
187. Mahapatro, A., and Singh, D. K. (2011). Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnology 9, 55. doi: 10.1186/1477-3155-9-55
188. Mahmoud, S. M., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H., et al. (2011). Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J. Clin. Oncol. 29, 1949-1955. doi: 10.1200/JCO.2010.30.5037
189. Mandal, S., Eksteen-Akeroyd, Z. H., Jacobs, M. J., Hammink, R., Koepf, M., Lambeck, A. J. A., et al. (2013). Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy. Chem. Sci. 4, 4168-4174. doi: 10.1039/C3sc51399h
190. Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., and Bachmann, M. F. (2008). Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404-1413. doi: 10.1002/eji.200737984
191. Mantovani, A., and Sica, A. (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237. doi: 10.1016/j.coi.2010.01.009
192. Marcu-Malina, V., Heijhuurs, S., Van Buuren, M., Hartkamp, L., Strand, S., Sebestyen, Z., et al. (2011). Redirecting alphabeta T cells against cancer cells by transfer of a broadly tumor-reactive gammadeltaT-cell receptor. Blood 118, 50-59. doi: 10.1182/blood-2010-12-325993
193. Matsumura, Y., and Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392.
194. Mellman, I., Coukos, G., and Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature 480, 480-489. doi: 10.1038/nature10673
195. Messina, J. L., Fenstermacher, D. A., Eschrich, S., Qu, X., Berglund, A. E., Lloyd, M. C., et al. (2012). 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci. Rep. 2:765. doi: 10.1038/srep00765
196. Mishra, R., Chen, A. T., Welsh, R. M., and Szomolanyi-Tsuda, E. (2010). NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors. PLoS Pathog. 6:e1000924. doi: 10.1371/journal.ppat.1000924
197. Mizrahy, S., and Peer, D. (2012). Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 41, 2623-2640. doi: 10.1039/c1cs15239d
198. Morales-Avila, E., Ferro-Flores, G., Ocampo-Garcia, B. E., De Leon-Rodriguez, L. M., Santos-Cuevas, C. L., Garcia-Becerra, R., et al. (2011). Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor alpha(v)beta(3) expression. Bioconjug. Chem. 22, 913-922. doi: 10.1021/bc100551s
199. Morales-Avila, E., Ferro-Flores, G., Ocampo-Garcia, B. E., and Gomez-Olivan, L. M. (2012). Engineered multifunctional RGD-gold nanoparticles for the detection of tumour-specific alpha(v)beta(3) expression: chemical characterisation and ecotoxicological risk assessment. J. Biomed. Nanotechnol. 8, 991-999. doi: 10.1166/jbn.2012.1452
200. Nam, S. J., Go, H., Paik, J. H., Kim, T. M., Heo, D. S., Kim, C. W., et al. (2014). An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk. Lymphoma. 55, 2466-2476. doi: 10.3109/10428194.2013.879713
201. Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., and Nanjwade, V. K. (2009). Dendrimers: emerging polymers for drug-delivery systems. Eur. J. Pharm. Sci. 38, 185-196. doi: 10.1016/j.ejps.2009.07.008
202. Naumova, A. V., Modo, M., Moore, A., Murry, C. E., and Frank, J. A. (2014). Clinical imaging in regenerative medicine. Nat. Biotechnol. 32, 804-818. doi: 10.1038/nbt.2993
203. Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., and Couvreur, P. (2013). Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 42, 1147-1235. doi: 10.1039/c2cs35265f
204. Niederhafner, P., Reinis, M., Sebestik, J., and Jezek, J. (2008). Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases. J. Pept. Sci. 14, 556-587. doi: 10.1002/psc.1011
205. Niino, D., Komohara, Y., Murayama, T., Aoki, R., Kimura, Y., Hashikawa, K., et al. (2010). Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol. Int. 60, 278-283. doi: 10.1111/j.1440-1827.2010.02514.x
206. Oble, D. A., Loewe, R., Yu, P., and Mihm, M. C. Jr. (2009). Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun. 9, 3.
207. Ocampo-Garcia, B., Ferro-Flores, G., Morales-Avila, E., and Ramirez Fde, M. (2011). Kit for preparation of multimeric receptor-specific (9)(9)mTc-radiopharmaceuticals based on gold nanoparticles. Nucl. Med. Commun. 32, 1095-1104. doi: 10.1097/MNM.0b013e32834acf33
208. Osaki, M., Kase, S., Adachi, K., Takeda, A., Hashimoto, K., and Ito, H. (2004). Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J. Cancer Res. Clin. Oncol. 130, 8-14. doi: 10.1007/s00432-003-0505-z
209. Ostrand-Rosenberg, S. (2004). Animal models of tumor immunity, immunotherapy and cancer vaccines. Curr. Opin. Immunol. 16, 143-150. doi: 10.1016/j.coi.2004.01.003
210. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., et al. (1998). Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 160, 1224-1232.
211. Palucka, K., and Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265-277. doi: 10.1038/nrc3258
212. Pan, J., and Feng, S. S. (2008). Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials 29, 2663-2672. doi: 10.1016/j.biomaterials.2008.02.020
213. Panyam, J., and Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347. doi: 10.1016/S0169-409X(02)00228-4
214. Park, J. H., Von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., et al. (2009). Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 5, 694-700. doi: 10.1002/smll.200801789
215. Partlow, K. C., Chen, J., Brant, J. A., Neubauer, A. M., Meyerrose, T. E., Creer, M. H., et al. (2007). 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 21, 1647-1654. doi: 10.1096/fj.06-6505com
216. Patel, S. K., Zhang, Y., Pollock, J. A., and Janjic, J. M. (2013). Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study. PLoS ONE 8:e55802. doi: 10.1371/journal.pone.0055802
217. Pedroza-Gonzalez, A., Xu, K., Wu, T. C., Aspord, C., Tindle, S., Marches, F., et al. (2011). Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J. Exp. Med. 208, 479-490. doi: 10.1084/jem.20102131
218. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760. doi: 10.1038/nnano.2007.387
219. Pejawar-Gaddy, S., Rajawat, Y., Hilioti, Z., Xue, J., Gaddy, D. F., Finn, O. J., et al. (2010). Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles. Cancer Immunol. Immunother. 59, 1685-1696. doi: 10.1007/s00262-010-0895-0
220. Pelkmans, L., and Helenius, A. (2002). Endocytosis via caveolae. Traffic 3, 311-320. doi: 10.1034/j.1600-0854.2002.30501.x
221. Peng, G., Wang, H. Y., Peng, W., Kiniwa, Y., Seo, K. H., and Wang, R. F. (2007). Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27, 334-348. doi: 10.1016/j.immuni.2007.05.020
222. Poulose, A. C., Veeranarayanan, S., Mohamed, M. S., Raveendran, S., Nagaoka, Y., Yoshida, Y., et al. (2012). PEG coated biocompatible cadmium chalcogenide quantum dots for targeted imaging of cancer cells. J. Fluoresc. 22, 931-944. doi: 10.1007/s10895-011-1032-y
223. Progatzky, F., Dallman, M. J., and Lo Celso, C. (2013). From seeing to believing: labelling strategies for in vivo cell-tracking experiments. Interface Focus 3, 20130001. doi: 10.1098/rsfs.2013.0001
224. Prokop, A., and Davidson, J. M. (2008). Nanovehicular intracellular delivery systems. J. Pharm. Sci. 97, 3518-3590. doi: 10.1002/jps.21270
225. Psimadas, D., Baldi, G., Ravagli, C., Bouziotis, P., Xanthopoulos, S., Franchini, M. C., et al. (2012). Preliminary evaluation of a 99mTc labeled hybrid nanoparticle bearing a cobalt ferrite core: in vivo biodistribution. J. Biomed. Nanotechnol. 8, 575-585. doi: 10.1166/jbn.2012.1412
226. Raaijmakers, M. I., Rozati, S., Goldinger, S. M., Widmer, D. S., Dummer, R., and Levesque, M. P. (2013). Melanoma immunotherapy: historical precedents, recent successes and future prospects. Immunotherapy 5, 169-182. doi: 10.2217/imt.12.162
227. Rabin, O., Manuel Perez, J., Grimm, J., Wojtkiewicz, G., and Weissleder, R. (2006). An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat. Mater. 5, 118-122. doi: 10.1038/nmat1571
228. Radford, K. J., and Caminschi, I. (2013). New generation of dendritic cell vaccines. Hum. Vaccin. Immunother. 9, 259-264.
229. Rahir, G., and Moser, M. (2012). Tumor microenvironment and lymphocyte infiltration. Cancer Immunol. Immunother. 61, 751-759. doi: 10.1007/s00262-012-1253-1
230. Rawat, M., Singh, D., Saraf, S., and Saraf, S. (2006). Nanocarriers: promising vehicle for bioactive drugs. Biol. Pharm. Bull. 29, 1790-1798. doi: 10.1248/bpb.29.1790
231. Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., et al. (2006). Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 12, 6677-6686. doi: 10.1158/1078-0432.CCR-06-0946
232. Reimer, P., and Balzer, T. (2003). Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 13, 1266-1276. doi: 10.1007/s00330-002-1721-7
233. Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., and Fuchs, H. (2009). Nanomedicine-challenge and perspectives. Angew. Chem. Int. Ed Engl. 48, 872-897. doi: 10.1002/anie.200802585
234. Rizvi, S. B., Rouhi, S., Taniguchi, S., Yang, S. Y., Green, M., Keshtgar, M., et al. (2014). Near-infrared quantum dots for HER2 localization and imaging of cancer cells. Int. J. Nanomedicine 9, 1323-1337. doi: 10.2147/IJN.S51535
235. Rohani, R., De Chickera, S. N., Willert, C., Chen, Y., Dekaban, G. A., and Foster, P. J. (2011). In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol. Imaging Biol. 13, 679-694. doi: 10.1007/s11307-010-0403-0
236. Roitt, I. M., and Delves, P. J. (2001). Roitt's Essential Immunology. Oxford: Blackwell Science.
237. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., et al. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
238. Rosenberg, S. A. (2001). Progress in human tumour immunology and immunotherapy. Nature 411, 380-384. doi: 10.1038/35077246
239. Rosenberg, S. A., Yang, J. C., and Restifo, N. P. (2004). Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915. doi: 10.1038/nm1100
240. Rosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., et al. (2011). Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550-4557. doi: 10.1158/1078-0432.CCR-11-0116
241. Ruan, G., Agrawal, A., Marcus, A. I., and Nie, S. (2007). Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J. Am. Chem. Soc. 129, 14759-14766. doi: 10.1021/ja074936k
242. Sahoo, S. K., and Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8, 1112-1120. doi: 10.1016/S1359-6446(03)02903-9
243. Santra, S., Dutta, D., Walter, G. A., and Moudgil, B. M. (2005). Fluorescent nanoparticle probes for cancer imaging. Technol. Cancer Res. Treat. 4, 593-602. doi: 10.1177/153303460500400603
244. Santra, S., and Malhotra, A. (2011). Fluorescent nanoparticle probes for imaging of cancer. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 501-510. doi: 10.1002/wnan.134
245. Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., et al. (2008). TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26, 1626-1637. doi: 10.1016/j.vaccine.2008.01.030
246. Schreiber, R. D., Old, L. J., and Smyth, M. J. (2011). Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570. doi: 10.1126/science.1203486
247. Sen, D., Deerinck, T. J., Ellisman, M. H., Parker, I., and Cahalan, M. D. (2008). Quantum dots for tracking dendritic cells and priming an immune response in vitro and in vivo. PLoS ONE 3:e3290. doi: 10.1371/journal.pone.0003290
248. Settles, M., Etzrodt, M., Kosanke, K., Schiemann, M., Zimmermann, A., Meier, R., et al. (2011). Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles. PLoS ONE 6:e25197. doi: 10.1371/journal.pone.0025197
249. Shahar, E., Gorodetsky, R., Gaberman, E., Aizenshtein, E., and Pitcovski, J. (2010). Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment. Vaccine 28, 7279-7287. doi: 10.1016/j.vaccine.2010.08.083
250. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., et al. (2001). IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111. doi: 10.1038/35074122
251. Sharma, A., Jain, N., and Sareen, R. (2013). Nanocarriers for diagnosis and targeting of breast cancer. Biomed Res. Int. 2013:960821. doi: 10.1155/2013/960821
252. Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., et al. (2009). Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 106, 870-875. doi: 10.1073/pnas.0804897106
253. Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., et al. (2006). Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117, 78-88. doi: 10.1111/j.1365-2567.2005.02268.x
254. Shen, L., Higuchi, T., Tubbe, I., Voltz, N., Krummen, M., Pektor, S., et al. (2013). A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo. PLoS ONE 8:e80904. doi: 10.1371/journal.pone.0080904
255. Shi, H., He, X., Yuan, Y., Wang, K., and Liu, D. (2010). Nanoparticle-based biocompatible and long-life marker for lysosome labeling and tracking. Anal. Chem. 82, 2213-2220. doi: 10.1021/ac902417s
256. Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M., and Swartz, M. A. (2010). Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752. doi: 10.1126/science.1185837
257. Shime, H., Matsumoto, M., Oshiumi, H., Tanaka, S., Nakane, A., Iwakura, Y., et al. (2012). Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc. Natl. Acad. Sci. U.S.A. 109, 2066-2071. doi: 10.1073/pnas.1113099109
258. Shimizu, K., Mizuno, T., Shinga, J., Asakura, M., Kakimi, K., Ishii, Y., et al. (2013). Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells. Cancer Res. 73, 62-73. doi: 10.1158/0008-5472.CAN-12-0759
259. Shubayev, V. I., Pisanic, T. R. 2nd., and Jin, S. (2009). Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61, 467-477. doi: 10.1016/j.addr.2009.03.007
260. Sica, A., and Mantovani, A. (2012). Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795. doi: 10.1172/JCI59643
261. Sica, A., Schioppa, T., Mantovani, A., and Allavena, P. (2006). Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727. doi: 10.1016/j.ejca.2006.01.003
262. Silva, J. M., Videira, M., Gaspar, R., Preat, V., and Florindo, H. F. (2013). Immune system targeting by biodegradable nanoparticles for cancer vaccines. J. Control. Release 168, 179-199. doi: 10.1016/j.jconrel.2013.03.010
263. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., and Coyle, A. J. (2010). HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367-388. doi: 10.1146/annurev.immunol.021908.132603
264. Singh, R., and Lillard, J. W. Jr. (2009). Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86, 215-223. doi: 10.1016/j.yexmp.2008.12.004
265. Slovin, S. F., Ragupathi, G., Musselli, C., Olkiewicz, K., Verbel, D., Kuduk, S. D., et al. (2003). Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine. J. Clin. Oncol. 21, 4292-4298. doi: 10.1200/JCO.2003.04.112
266. Smirnov, P., Lavergne, E., Gazeau, F., Lewin, M., Boissonnas, A., Doan, B. T., et al. (2006). In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn. Reson. Med. 56, 498-508. doi: 10.1002/mrm.20996
267. Smith, P. J., Giroud, M., Wiggins, H. L., Gower, F., Thorley, J. A., Stolpe, B., et al. (2012). Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int. J. Nanomedicine 7, 2045-2055. doi: 10.2147/IJN.S29334
268. Sosnovik, D. E., and Nahrendorf, M. (2012). Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ. Cardiovasc. Imaging 5, 551-554. doi: 10.1161/CIRCIMAGING.112.978932
269. Sperling, R. A., and Parak, W. J. (2010). Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos. Trans. A Math. Phys. Eng. Sci. 368, 1333-1383. doi: 10.1098/rsta.2009.0273
270. Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., et al. (2013). Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. Sci. Transl. Med. 5, 200ra116. doi: 10.1126/scitranslmed.3006504
271. Srinivas, M., Boehm-Sturm, P., Figdor, C. G., De Vries, I. J., and Hoehn, M. (2012). Labeling cells for in vivo tracking using (19)F MRI. Biomaterials 33, 8830-8840. doi: 10.1016/j.biomaterials.2012.08.048
272. Srinivas, M., Turner, M. S., Janjic, J. M., Morel, P. A., Laidlaw, D. H., and Ahrens, E. T. (2009). In vivo cytometry of antigen-specific t cells using 19F MRI. Magn. Reson. Med. 62, 747-753. doi: 10.1002/mrm.22063
273. Stelter, L., Pinkernelle, J. G., Michel, R., Schwartlander, R., Raschzok, N., Morgul, M. H., et al. (2010). Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol. Imaging Biol. 12, 25-34. doi: 10.1007/s11307-009-0237-9
274. Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., and Irvine, D. J. (2010). Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat. Med. 16, 1035-1041. doi: 10.1038/nm.2198
275. Swann, J. B., and Smyth, M. J. (2007). Immune surveillance of tumors. J. Clin. Invest. 117, 1137-1146. doi: 10.1172/JCI31405
276. Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., et al. (2011). MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 32, 6570-6578. doi: 10.1016/j.biomaterials.2011.05.029
277. Tanaka, E., Choi, H. S., Fujii, H., Bawendi, M. G., and Frangioni, J. V. (2006). Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann. Surg. Oncol. 13, 1671-1681. doi: 10.1245/s10434-006-9194-6
278. Tari, A., Khodadadian, M., Ellerson, D., Deisseroth, A., and Lopez-Berestein, G. (1996). Liposomal delivery of oligodeoxynucleotides. Leuk. Lymphoma 21, 93-97. doi: 10.3109/10428199609067585
279. Thiele, L., Merkle, H. P., and Walter, E. (2003). Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm. Res. 20, 221-228. doi: 10.1023/A:1022271020390
280. Thomas, L. (1982). On immunosurveillance in human cancer. Yale J. Biol. Med. 55, 329-333.
281. Thorek, D. L., and Tsourkas, A. (2008). Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583-3590. doi: 10.1016/j.biomaterials.2008.05.015
282. Thu, M. S., Bryant, L. H., Coppola, T., Jordan, E. K., Budde, M. D., Lewis, B. K., et al. (2012). Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 18, 463-467. doi: 10.1038/nm.2666
283. Thu, M. S., Najbauer, J., Kendall, S. E., Harutyunyan, I., Sangalang, N., Gutova, M., et al. (2009). Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS ONE 4:e7218. doi: 10.1371/journal.pone.0007218
284. Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137-172. doi: 10.1016/S0168-3659(01)00299-1
285. Torchilin, V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131-135. doi: 10.1016/j.addr.2010.03.011
286. Torchilin, V. P. (2008). Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90, 604-610. doi: 10.1002/bip.20989
287. Toulza, F., Nosaka, K., Tanaka, Y., Schioppa, T., Balkwill, F., Taylor, G. P., et al. (2010). Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J. Immunol. 185, 183-189. doi: 10.4049/jimmunol.0903846
288. Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., et al. (1996). High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110, 375-382.
289. Unger, W. W., and Van Kooyk, Y. (2011). "Dressed for success" C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells. Curr. Opin. Immunol. 23, 131-137. doi: 10.1016/j.coi.2010.11.011
290. U'ren, L., Kedl, R., and Dow, S. (2006). Vaccination with liposome-DNA complexes elicits enhanced antitumor immunity. Cancer Gene. Ther. 13, 1033-1044. doi: 10.1038/sj.cgt.7700982
291. Uyttenhove, C., Godfraind, C., Lethe, B., Amar-Costesec, A., Renauld, J. C., Gajewski, T. F., et al. (1997). The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int. J. Cancer 70, 349-356.
292. Vacchelli, E., Martins, I., Eggermont, A., Fridman, W. H., Galon, J., Sautes-Fridman, C., et al. (2012). Trial watch: peptide vaccines in cancer therapy. Oncoimmunology 1, 1557-1576. doi: 10.4161/onci.22428
293. Van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., and Altin, J. G. (2004). Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. 64, 4357-4365. doi: 10.1158/0008-5472.CAN-04-0138
294. Van Kooyk, Y. (2008). C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem. Soc. Trans. 36, 1478-1481. doi: 10.1042/BST0361478
295. Vesely, M. D., Kershaw, M. H., Schreiber, R. D., and Smyth, M. J. (2011). Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235-271. doi: 10.1146/annurev-immunol-031210-101324
296. Vonderheide, R. H., Bajor, D. L., Winograd, R., Evans, R. A., Bayne, L. J., and Beatty, G. L. (2013). CD40 immunotherapy for pancreatic cancer. Cancer Immunol. Immunother. 62, 949-954. doi: 10.1007/s00262-013-1427-5
297. Voura, E. B., Jaiswal, J. K., Mattoussi, H., and Simon, S. M. (2004). Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat. Med. 10, 993-998. doi: 10.1038/nm1096
298. Vu-Quang, H., Muthiah, M., Lee, H. J., Kim, Y. K., Rhee, J. H., Lee, J. H., et al. (2012). Immune cell-specific delivery of beta-glucan-coated iron oxide nanoparticles for diagnosing liver metastasis by MR imaging. Carbohydr. Polym. 87, 1159-1168. doi: 10.1016/j.carbpol.2011.08.091
299. Wang, H. X., Xiong, M. H., Wang, Y. C., Zhu, J., and Wang, J. (2013a). N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver. J. Control. Release 166, 106-114. doi: 10.1016/j.jconrel.2012.12.017
300. Wang, K., He, X., Yang, X., and Shi, H. (2013b). Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels. Acc. Chem. Res. 46, 1367-1376. doi: 10.1021/ar3001525
301. Wang, X., Xing, X., Zhang, B., Liu, F., Cheng, Y., and Shi, D. (2014). Surface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells. Int. J. Nanomedicine 9, 1601-1615. doi: 10.2147/IJN.S58334
302. Wang, Y. X., Hussain, S. M., and Krestin, G. P. (2001). Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11, 2319-2331. doi: 10.1007/s003300100908
303. Watkins, S. K., Zhu, Z., Riboldi, E., Shafer-Weaver, K. A., Stagliano, K. E., Sklavos, M. M., et al. (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J. Clin. Invest. 121, 1361-1372. doi: 10.1172/JCI44325
304. Weng, K. C., Noble, C. O., Papahadjopoulos-Sternberg, B., Chen, F. F., Drummond, D. C., Kirpotin, D. B., et al. (2008). Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett. 8, 2851-2857. doi: 10.1021/nl801488u
305. Wesch, D., Peters, C., Oberg, H. H., Pietschmann, K., and Kabelitz, D. (2011). Modulation of gammadelta T cell responses by TLR ligands. Cell. Mol. Life Sci. 68, 2357-2370. doi: 10.1007/s00018-011-0699-1
306. Wilson, J. T., Keller, S., Manganiello, M. J., Cheng, C., Lee, C. C., Opara, C., et al. (2013). pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano 7, 3912-3925. doi: 10.1021/nn305466z
307. Wong, A. D., Dewit, M. A., and Gillies, E. R. (2012). Amplified release through the stimulus triggered degradation of self-immolative oligomers, dendrimers, and linear polymers. Adv. Drug Deliv. Rev. 64, 1031-1045. doi: 10.1016/j.addr.2011.09.012
308. Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., and Li, Y. (2014). Peptide-based cancer therapy: opportunity and challenge. Cancer Lett. 351, 13-22. doi: 10.1016/j.canlet.2014.05.002
309. Xiang, S. D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P. L., et al. (2006). Pathogen recognition and development of particulate vaccines: does size matter? Methods 40, 1-9. doi: 10.1016/j.ymeth.2006.05.016
310. Xie, H., Diagaradjane, P., Deorukhkar, A. A., Goins, B., Bao, A., Phillips, W. T., et al. (2011). Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int. J. Nanomedicine 6, 259-269. doi: 10.2147/IJN.S15479
311. Xie, J., Chen, K., Huang, J., Lee, S., Wang, J., Gao, J., et al. (2010). PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31, 3016-3022. doi: 10.1016/j.biomaterials.2010.01.010
312. Xu, Z., Wang, Y., Zhang, L., and Huang, L. (2014). Nanoparticle-delivered transforming growth factor-beta siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment. ACS Nano 8, 3636-3645. doi: 10.1021/nn500216y
313. Yaghoubi, S. S., Jensen, M. C., Satyamurthy, N., Budhiraja, S., Paik, D., Czernin, J., et al. (2009). Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat. Clin. Pract. Oncol. 6, 53-58. doi: 10.1038/ncponc1278
314. Yang, J., Lee, C. H., Ko, H. J., Suh, J. S., Yoon, H. G., Lee, K., et al. (2007). Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew. Chem. Int. Ed. Engl. 46, 8836-8839. doi: 10.1002/anie.200703554
315. Yang, W., Cheng, Y., Xu, T., Wang, X., and Wen, L. P. (2009). Targeting cancer cells with biotin-dendrimer conjugates. Eur. J. Med. Chem. 44, 862-868. doi: 10.1016/j.ejmech.2008.04.021
316. Yoo, H. S., and Park, T. G. (2004). Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release 96, 273-283. doi: 10.1016/j.jconrel.2004.02.003
317. Yoshikawa, T., Okada, N., Oda, A., Matsuo, K., Matsuo, K., Kayamuro, H., et al. (2008). Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. Vaccine 26, 1303-1313. doi: 10.1016/j.vaccine.2007.12.037
318. Yu, M. K., Park, J., and Jon, S. (2012). Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2, 3-44. doi: 10.7150/thno.3463
319. Yu, X., Chen, L., Li, K., Li, Y., Xiao, S., Luo, X., et al. (2007). Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J. Biomed. Opt. 12, 014008. doi: 10.1117/1.2437744
320. Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55, 3752-3756.
321. Yue, Z. G., Wei, W., Lv, P. P., Yue, H., Wang, L. Y., Su, Z. G., et al. (2011). Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12, 2440-2446. doi: 10.1021/bm101482r
322. Zavaleta, C., De La Zerda, A., Liu, Z., Keren, S., Cheng, Z., Schipper, M., et al. (2008). Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett. 8, 2800-2805. doi: 10.1021/nl801362a
323. Zhang, L., Zhou, H., Belzile, O., Thorpe, P., and Zhao, D. (2014). Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. J. Control. Release 183, 114-123. doi: 10.1016/j.jconrel.2014.03.043
324. Zhang, Q., Zhang, A., Yang, P., and Shen, J. (2013). Synthesis of CdSe quantum dots using various long-chain fatty acids and their phase transfer. J. Nanosci. Nanotechnol. 13, 4235-4241.: 10.1166/jnn.2013.7433
325. Zhang, Z., Jiang, Q., Jiang, F., Ding, G., Zhang, R., Wang, L., et al. (2004). In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23, 281-287. doi: 10.1016/j.neuroimage.2004.05.019
326. Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., et al. (2011). Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials 32, 3666-3678. doi: 10.1016/j.biomaterials.2011.01.067
327. Zhou, Y., Zhang, C., and Liang, W. (2014). Development of RNAi technology for targeted therapy-a track of siRNA based agents to RNAi therapeutics. J. Control. Release. doi: 10.1016/j.jconrel.2014.04.044. [Epub ahead of print].
328. Zitvogel, L., Tesniere, A., and Kroemer, G. (2006). Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6, 715-727. doi: 10.1038/nri1936
329. Zou, W. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5, 263-274. doi: 10.1038/nrc1586